23.11.2023 13:00
Evolva Holding SA, a pioneer in natural molecules and industrial biotech, faced the risk of shutting down its wholly-owned operating subsidiary, Evolva AG, due to financial difficulties. To avoid this, the company agreed to sell all of its business operations to Danstar Ferment AG, a Swiss affiliate of Lallemand Inc., for CHF 20 million. This deal is considered the best possible outcome for the company and its stakeholders.